Parkside Financial Bank & Trust Aerie Pharmaceuticals Inc Transaction History

Parkside Financial Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$36.32 - $49.25 $13,256 - $17,976	-365 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$33.0 - $60.04 $1,650 - $3,002	50 Added 15.87%	365 $13,000
Q2 2018 Aug 03, 2018	BUY	$47.85 - $70.45 $4,115 - $6,058	86 Added 37.55%	315 $21,000
Q4 2017 Feb 05, 2018	BUY	$50.85 - $65.1 $1,830 - $2,343	36 Added 18.65%	229 $14,000
Q3 2017 Oct 27, 2017	BUY	$48.6 - $60.1 $9,379 - $11,599	193	193 $9,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.